US Stock MarketDetailed Quotes

SBFM Sunshine Biopharma

Watchlist
  • 3.1000
  • +0.2400+8.39%
Close Dec 2 16:00 ET
  • 3.0600
  • -0.0400-1.29%
Post 20:01 ET
6.20MMarket Cap-24P/E (TTM)

Sunshine Biopharma Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
41.59%8.44M
67.30%9.3M
54.09%7.54M
454.42%24.09M
94.94%7.68M
4,385.93%5.96M
3,599.67%5.56M
3,890.42%4.89M
1,802.41%4.35M
4,528.68%3.94M
Operating revenue
41.59%8.44M
67.30%9.3M
54.09%7.54M
454.42%24.09M
94.94%7.68M
4,385.93%5.96M
3,599.67%5.56M
3,890.42%4.89M
1,802.41%4.35M
4,528.68%3.94M
Cost of revenue
40.37%5.57M
92.53%6.95M
69.17%5.19M
494.69%15.75M
108.77%5.11M
5,931.06%3.97M
4,731.24%3.61M
5,023.12%3.07M
2,148.18%2.65M
3,895.36%2.45M
Gross profit
44.01%2.87M
20.66%2.36M
28.78%2.35M
391.53%8.34M
72.22%2.57M
2,869.42%1.99M
2,482.18%1.95M
2,811.02%1.83M
1,434.03%1.7M
6,157.61%1.49M
Operating expense
43.43%3.97M
22.18%3.62M
1.31%3.7M
26.55%13.12M
-42.47%3.76M
55.17%2.77M
284.57%2.97M
184.34%3.66M
306.57%10.37M
2,051.20%6.53M
Selling and administrative expenses
52.55%3.73M
21.29%2.99M
7.63%3.36M
14.26%10.83M
-56.02%2.82M
71.76%2.44M
241.06%2.47M
239.24%3.13M
408.01%9.48M
2,966.82%6.41M
-Selling and marketing expense
16.89%282.75K
92.47%256.33K
54.83%198.05K
27.01%734.25K
30.14%231.26K
11.13%241.9K
51.89%133.18K
34.59%127.91K
--578.09K
--177.7K
-General and administrative expense
56.47%3.44M
17.23%2.74M
5.62%3.17M
13.43%10.1M
-58.48%2.59M
82.72%2.2M
267.16%2.33M
262.78%3M
377.03%8.9M
2,881.83%6.23M
Research and development costs
-46.91%126.36K
18.36%436.24K
-48.71%222.03K
128.59%1.86M
1,854.67%816.33K
-34.34%238.01K
702.22%368.57K
19.71%432.93K
20.77%811.86K
-54.21%41.76K
Depreciation amortization depletion
73.68%64.63K
45.86%50.87K
22.78%42.62K
492.72%149.15K
123.16%42.35K
4,616.10%37.21K
1,425.01%34.88K
1,016.08%34.71K
97.50%25.16K
496.01%18.98K
-Depreciation and amortization
73.68%64.63K
45.86%50.87K
22.78%42.62K
492.72%149.15K
123.16%42.35K
4,616.10%37.21K
1,425.01%34.88K
1,016.08%34.71K
97.50%25.16K
496.01%18.98K
Other taxes
7.39%56.47K
50.86%145.81K
19.12%75.9K
424.57%289.74K
39.02%76.78K
--52.59K
--96.65K
--63.72K
--55.23K
--55.23K
Operating profit
-41.94%-1.11M
-25.09%-1.27M
26.16%-1.35M
44.83%-4.79M
76.43%-1.19M
54.63%-779.47K
-45.72%-1.01M
-49.50%-1.83M
-255.47%-8.67M
-1,701.26%-5.04M
Net non-operating interest income expense
-35.69%108.61K
-28.02%143.75K
-45.08%94.91K
40.78%674.67K
85.04%157.5K
-35.27%168.9K
36.75%199.72K
1,443.64%172.81K
245.75%479.24K
332.38%85.12K
Non-operating interest income
-47.64%108.61K
-29.08%144K
-32.63%144.09K
56.56%811.97K
68.01%187.61K
-20.51%207.43K
39.03%203.05K
7,129,266.67%213.88K
--518.65K
--111.67K
Non-operating interest expense
--0
-92.64%245
19.73%49.18K
248.39%137.31K
13.43%30.11K
1,926,250.00%38.53K
--3.33K
219.30%41.08K
-88.01%39.41K
-27.53%26.55K
Other net income (expense)
37,782.50%15.15K
109,883.52%286.54K
-38,546.67%-5.77K
100.00%-245
100.00%-39
60.00%40
-102.40%-261
266.67%15
-89.46%-18.32M
-1,963.70%-18.33M
Gain on sale of security
37,782.50%15.15K
109,883.52%286.54K
-38,546.67%-5.77K
48.53%-245
92.51%-39
60.00%40
-1,000.00%-261
266.67%15
-1,052.00%-476
-2,842.11%-521
Special income (charges)
----
----
----
--0
----
----
----
----
-89.46%-18.32M
-1,963.69%-18.33M
-Less:Impairment of capital assets
----
----
----
--0
----
----
----
----
--18.33M
----
-Less:Other special charges
----
----
----
----
----
----
----
----
-100.11%-10.85K
--0
Income before tax
-60.94%-982.59K
-2.89%-837.99K
23.83%-1.26M
84.49%-4.11M
95.58%-1.03M
58.10%-610.53K
-51.14%-814.43K
-33.97%-1.66M
-113.17%-26.51M
-3,589.50%-23.28M
Income tax
425.53%215.22K
-492.00%-343.69K
-51.69%22.35K
69.38%395.17K
-5.59%220.27K
40.95K
87.68K
46.27K
233.3K
233.3K
Net income
-83.86%-1.2M
45.21%-494.3K
24.59%-1.28M
83.15%-4.51M
94.68%-1.25M
55.29%-651.48K
-67.41%-902.11K
-37.71%-1.7M
-115.05%-26.74M
-3,624.47%-23.51M
Net income continuous Operations
-83.86%-1.2M
45.21%-494.3K
24.59%-1.28M
83.15%-4.51M
94.68%-1.25M
55.29%-651.48K
-67.41%-902.11K
-37.71%-1.7M
-115.05%-26.74M
-3,624.47%-23.51M
Minority interest income
Net income attributable to the parent company
-83.86%-1.2M
45.21%-494.3K
24.59%-1.28M
83.15%-4.51M
94.68%-1.25M
55.29%-651.48K
-67.41%-902.11K
-37.71%-1.7M
-115.05%-26.74M
-3,624.47%-23.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-83.86%-1.2M
45.21%-494.3K
24.59%-1.28M
83.15%-4.51M
94.68%-1.25M
55.29%-651.48K
-67.41%-902.11K
-37.71%-1.7M
-115.05%-26.74M
-3,624.47%-23.51M
Basic earnings per share
98.15%-0.94
86.03%-0.0994
74.13%-40
89.20%-380
96.19%-114.29
68.30%-50.72
98.81%-0.7117
66.39%-154.6
63.03%-3.52K
-254.64%-3K
Diluted earnings per share
98.15%-0.94
86.03%-0.0994
74.13%-40
89.20%-380
96.19%-114.29
68.30%-50.72
98.81%-0.7117
67.03%-154.6
63.03%-3.52K
-682.36%-3K
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 41.59%8.44M67.30%9.3M54.09%7.54M454.42%24.09M94.94%7.68M4,385.93%5.96M3,599.67%5.56M3,890.42%4.89M1,802.41%4.35M4,528.68%3.94M
Operating revenue 41.59%8.44M67.30%9.3M54.09%7.54M454.42%24.09M94.94%7.68M4,385.93%5.96M3,599.67%5.56M3,890.42%4.89M1,802.41%4.35M4,528.68%3.94M
Cost of revenue 40.37%5.57M92.53%6.95M69.17%5.19M494.69%15.75M108.77%5.11M5,931.06%3.97M4,731.24%3.61M5,023.12%3.07M2,148.18%2.65M3,895.36%2.45M
Gross profit 44.01%2.87M20.66%2.36M28.78%2.35M391.53%8.34M72.22%2.57M2,869.42%1.99M2,482.18%1.95M2,811.02%1.83M1,434.03%1.7M6,157.61%1.49M
Operating expense 43.43%3.97M22.18%3.62M1.31%3.7M26.55%13.12M-42.47%3.76M55.17%2.77M284.57%2.97M184.34%3.66M306.57%10.37M2,051.20%6.53M
Selling and administrative expenses 52.55%3.73M21.29%2.99M7.63%3.36M14.26%10.83M-56.02%2.82M71.76%2.44M241.06%2.47M239.24%3.13M408.01%9.48M2,966.82%6.41M
-Selling and marketing expense 16.89%282.75K92.47%256.33K54.83%198.05K27.01%734.25K30.14%231.26K11.13%241.9K51.89%133.18K34.59%127.91K--578.09K--177.7K
-General and administrative expense 56.47%3.44M17.23%2.74M5.62%3.17M13.43%10.1M-58.48%2.59M82.72%2.2M267.16%2.33M262.78%3M377.03%8.9M2,881.83%6.23M
Research and development costs -46.91%126.36K18.36%436.24K-48.71%222.03K128.59%1.86M1,854.67%816.33K-34.34%238.01K702.22%368.57K19.71%432.93K20.77%811.86K-54.21%41.76K
Depreciation amortization depletion 73.68%64.63K45.86%50.87K22.78%42.62K492.72%149.15K123.16%42.35K4,616.10%37.21K1,425.01%34.88K1,016.08%34.71K97.50%25.16K496.01%18.98K
-Depreciation and amortization 73.68%64.63K45.86%50.87K22.78%42.62K492.72%149.15K123.16%42.35K4,616.10%37.21K1,425.01%34.88K1,016.08%34.71K97.50%25.16K496.01%18.98K
Other taxes 7.39%56.47K50.86%145.81K19.12%75.9K424.57%289.74K39.02%76.78K--52.59K--96.65K--63.72K--55.23K--55.23K
Operating profit -41.94%-1.11M-25.09%-1.27M26.16%-1.35M44.83%-4.79M76.43%-1.19M54.63%-779.47K-45.72%-1.01M-49.50%-1.83M-255.47%-8.67M-1,701.26%-5.04M
Net non-operating interest income expense -35.69%108.61K-28.02%143.75K-45.08%94.91K40.78%674.67K85.04%157.5K-35.27%168.9K36.75%199.72K1,443.64%172.81K245.75%479.24K332.38%85.12K
Non-operating interest income -47.64%108.61K-29.08%144K-32.63%144.09K56.56%811.97K68.01%187.61K-20.51%207.43K39.03%203.05K7,129,266.67%213.88K--518.65K--111.67K
Non-operating interest expense --0-92.64%24519.73%49.18K248.39%137.31K13.43%30.11K1,926,250.00%38.53K--3.33K219.30%41.08K-88.01%39.41K-27.53%26.55K
Other net income (expense) 37,782.50%15.15K109,883.52%286.54K-38,546.67%-5.77K100.00%-245100.00%-3960.00%40-102.40%-261266.67%15-89.46%-18.32M-1,963.70%-18.33M
Gain on sale of security 37,782.50%15.15K109,883.52%286.54K-38,546.67%-5.77K48.53%-24592.51%-3960.00%40-1,000.00%-261266.67%15-1,052.00%-476-2,842.11%-521
Special income (charges) --------------0-----------------89.46%-18.32M-1,963.69%-18.33M
-Less:Impairment of capital assets --------------0------------------18.33M----
-Less:Other special charges ---------------------------------100.11%-10.85K--0
Income before tax -60.94%-982.59K-2.89%-837.99K23.83%-1.26M84.49%-4.11M95.58%-1.03M58.10%-610.53K-51.14%-814.43K-33.97%-1.66M-113.17%-26.51M-3,589.50%-23.28M
Income tax 425.53%215.22K-492.00%-343.69K-51.69%22.35K69.38%395.17K-5.59%220.27K40.95K87.68K46.27K233.3K233.3K
Net income -83.86%-1.2M45.21%-494.3K24.59%-1.28M83.15%-4.51M94.68%-1.25M55.29%-651.48K-67.41%-902.11K-37.71%-1.7M-115.05%-26.74M-3,624.47%-23.51M
Net income continuous Operations -83.86%-1.2M45.21%-494.3K24.59%-1.28M83.15%-4.51M94.68%-1.25M55.29%-651.48K-67.41%-902.11K-37.71%-1.7M-115.05%-26.74M-3,624.47%-23.51M
Minority interest income
Net income attributable to the parent company -83.86%-1.2M45.21%-494.3K24.59%-1.28M83.15%-4.51M94.68%-1.25M55.29%-651.48K-67.41%-902.11K-37.71%-1.7M-115.05%-26.74M-3,624.47%-23.51M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -83.86%-1.2M45.21%-494.3K24.59%-1.28M83.15%-4.51M94.68%-1.25M55.29%-651.48K-67.41%-902.11K-37.71%-1.7M-115.05%-26.74M-3,624.47%-23.51M
Basic earnings per share 98.15%-0.9486.03%-0.099474.13%-4089.20%-38096.19%-114.2968.30%-50.7298.81%-0.711766.39%-154.663.03%-3.52K-254.64%-3K
Diluted earnings per share 98.15%-0.9486.03%-0.099474.13%-4089.20%-38096.19%-114.2968.30%-50.7298.81%-0.711767.03%-154.663.03%-3.52K-682.36%-3K
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data